|
|
|
Volumn 27 Suppl, Issue , 2007, Pages 3-11
|
|
Hormone ablation therapy: lightening the load for today's prostate cancer patient.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABARELIX;
ANTIANDROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
FINASTERIDE;
FLUTAMIDE;
GONADORELIN;
LEUPRORELIN;
OLIGOPEPTIDE;
PROSTATE SPECIFIC ANTIGEN;
STEROID 5ALPHA REDUCTASE;
BLOOD;
CANCER STAGING;
DRUG ANTAGONISM;
DRUG MONITORING;
DRUG POTENTIATION;
HUMAN;
MALE;
MASS SCREENING;
MULTIMODALITY CANCER THERAPY;
NURSE ATTITUDE;
NURSING ASSESSMENT;
PATIENT EDUCATION;
PROSTATE TUMOR;
PROSTATECTOMY;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
REVIEW;
TREATMENT OUTCOME;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
COMBINED MODALITY THERAPY;
DRUG MONITORING;
FINASTERIDE;
FLUTAMIDE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
LEUPROLIDE;
MALE;
MASS SCREENING;
NEOPLASM STAGING;
NURSE'S ROLE;
NURSING ASSESSMENT;
OLIGOPEPTIDES;
PATIENT EDUCATION;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
TESTOSTERONE 5-ALPHA-REDUCTASE;
TREATMENT OUTCOME;
|
|
EID: 34248589355
PISSN: 1053816X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (7)
|
|
References (60)
|
